5-fluorotryptamine monohydrochloride has been researched along with (1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol in 1 studies
| Studies (5-fluorotryptamine monohydrochloride) | Trials (5-fluorotryptamine monohydrochloride) | Recent Studies (post-2010) (5-fluorotryptamine monohydrochloride) | Studies ((1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol) | Trials ((1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol) | Recent Studies (post-2010) ((1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol) |
|---|---|---|---|---|---|
| 6 | 0 | 2 | 17 | 0 | 12 |
| Protein | Taxonomy | 5-fluorotryptamine monohydrochloride (IC50) | (1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 4.76 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 2.53 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.7944 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.7221 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.4004 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 4.561 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 4.4868 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.0232 | |
| Adenosine receptor A3 | Homo sapiens (human) | 3.7058 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 4.505 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 4.9963 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.7058 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.446 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.5435 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 4.6238 | |
| Substance-K receptor | Homo sapiens (human) | 6.7929 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.4004 | |
| Histamine H2 receptor | Homo sapiens (human) | 0.1081 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.5435 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.2532 | |
| Histamine H1 receptor | Homo sapiens (human) | 5.1768 | |
| D(3) dopamine receptor | Homo sapiens (human) | 2.1039 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.939 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.7058 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.57 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.1172 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
1 other study(ies) available for 5-fluorotryptamine monohydrochloride and (1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |